Expanding research in Leeds for patients with a rare autoimmune disease.

A2002997

Systemic sclerosis (SSc) is a chronic, multi organ, autoimmune disease. SSc is a rare disease with patients unfortunately suffering the highest morbidity and mortality amongst rheumatic diseases. 
 
The Leeds Raynaud’s and Scleroderma programme aims to improve: 
 
• Early diagnosis for patients at risk of SSc 
• Clinical management for patients diagnosed with SSc 
• Quality of life for all patients  
 
Leeds is an internationally renowned centre of excellence for SSc. Research is embedded into clinical practice, offering patients access to novel treatments and techniques to diagnose and manage their condition. 

Lead Researcher	Dr Lesley-Anne Bissell
Host Organisation	University of Leeds
Grant Amount	£68,090.00
Start Date	02/09/2024
Estimated Duration	36 months
Impact Areas	Treatment of Rare Conditions
Tags/key notes	Inflammatory and Immune System